NCT04770597

Brief Summary

Ventilation with fresh outdoor air has recently gained considerable attention as a means to reduce the potential risk of indoor aerosol transmission of respiratory pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19). Commercial carbon dioxide (CO2) monitors are increasingly used in schools, long-term care facilities, offices and public buildings to monitor indoor ventilation. However, no formal evidence is available to support the effectiveness of feedback from CO2 monitoring devices. Moreover, modern hospitals have superior indoor air quality control systems. The aim of this prospective pilot randomized controlled trial (RCT) is to evaluate whether CO2 monitoring devices would be useful as a means to further maintain lower indoor CO2 concentrations in hospitals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

February 21, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 25, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2021

Completed
Last Updated

May 11, 2021

Status Verified

May 1, 2021

Enrollment Period

2 months

First QC Date

February 16, 2021

Last Update Submit

May 7, 2021

Conditions

Keywords

Indoor air qualityCarbon dioxideVentilation

Outcome Measures

Primary Outcomes (1)

  • Time >800 ppm CO2

    Time/day (in minutes/24h) measuring \>800 ppm CO2

    7 days/time period (pre-, active/sham and post-intervention)

Secondary Outcomes (3)

  • Time >1000 ppm CO2

    7 days/time period (pre-, active/sham and post-intervention)

  • Time >1400 ppm CO2

    7 days/time period (pre-, active/sham and post-intervention)

  • Daily peak CO2 concentration [in ppm]

    7 days/time period (pre-, active/sham and post-intervention)

Other Outcomes (2)

  • Staff-rated feasibility on a 10-point Likert scale [0-10, with 10 indicating better outcome]

    7 days

  • Staff-rated preference on a 10-point Likert scale [0-10, with 10 indicating better outcome]

    7 days

Study Arms (2)

Intervention

EXPERIMENTAL

CO2 values on sensor visible to staff

Device: Aranet4 Home CO2 monitor

Sham control

SHAM COMPARATOR

CO2 values on sensor not visible to staff

Device: Aranet4 Home CO2 monitor

Interventions

The sensor is placed in the room at a height between 1 and 2 meters and not near the window or door.

InterventionSham control

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsWhen applicable, patients stay in double-bed rooms based on gender.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Double-bed hospital rooms

You may not qualify if:

  • Unoccupied rooms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imelda Hospital

Bonheiden, 2820, Belgium

Location

Related Publications (1)

  • Laurent MR, Frans J. Monitors to improve indoor air carbon dioxide concentrations in the hospital: A randomized crossover trial. Sci Total Environ. 2022 Feb 1;806(Pt 3):151349. doi: 10.1016/j.scitotenv.2021.151349. Epub 2021 Oct 30.

MeSH Terms

Conditions

Cross InfectionRespiratory Aspiration

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Michaël R Laurent, MD PhD

    Geriatrics Department, Imelda Hospital Bonheiden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: Each sensor will be randomized to Sham-Intervention or Intervention-Sham cross-over. Additionally, each sensor will measure CO2 during a baseline and post-intervention phase.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2021

First Posted

February 25, 2021

Study Start

February 21, 2021

Primary Completion

May 2, 2021

Study Completion

May 2, 2021

Last Updated

May 11, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

The full set of sensor data will be made available to established investigators upon simple request.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will be available upon fulltext print publication in a peer-reviewed journal, for a duration of at least 10 years.
Access Criteria
Simple e-mail request to the corresponding author by an established scientific investigator

Locations